Contrafect Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contrafect daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contrafect Daily Today - Breaking & Trending Today

ContraFect (NASDAQ:CFRX) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report issued on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Stock Down 28.0 % CFRX opened at $0.05 on Friday. The company has a market cap of $535,000.00, a price-to-earnings ratio of 0.00 and a beta […] ....

United States , Contrafect Company Profile , Contrafect Corporation , Vanguard Group Inc , Renaissance Technologies , Armistice Capital , Goldman Sachs Group Inc , Virtu Financial , Free Report , Fect Stock Down , Get Free Report , Sachs Group , Fect Corporation , Contrafect Daily , Nasdaq Cfrx , Initiated Coverage , Stocknews Com ,

ContraFect (NASDAQ:CFRX) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Price Performance ContraFect stock opened at $0.05 on Friday. The stock has a market capitalization of $535,000.00, a price-to-earnings ratio of 0.00 and a […] ....

United States , Contrafect Corporation , Armistice Capital , Renaissance Technologies , Envestnet Asset Management Inc , Virtu Financial , Free Report , Get Free Report , Sigma Investments , Asset Management , Fect Corporation , Contrafect Daily , Nasdaq Cfrx , Initiated Coverage , Stocknews Com ,

ContraFect (NASDAQ:CFRX) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report released on Saturday. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Stock Performance Shares of NASDAQ CFRX opened at $0.05 on Friday. The firm has a market cap of $535,000.00, a P/E ratio of 0.00 and a […] ....

United States , Virtu Financial , Armistice Capital , Contrafect Corporation , Renaissance Technologies , Goldman Sachs Group Inc , Free Report , Get Free Report , Sigma Investments , Goldman Sachs Group , Sachs Group , Fect Corporation , Contrafect Daily , Nasdaq Cfrx , Initiated Coverage , Stocknews Com ,

ContraFect (NASDAQ:CFRX) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research note published on Thursday. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Stock Performance CFRX stock opened at $0.05 on Thursday. ContraFect has a fifty-two week low of $0.04 and a fifty-two week high of $13.02. The […] ....

United States , Contrafect Corporation , Goldman Sachs Group Inc , Armistice Capital , Virtu Financial , Vanguard Group Inc , Renaissance Technologies , Free Report , Get Free Report , Sachs Group , Fect Corporation , Contrafect Daily , Nasdaq Cfrx , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on ContraFect (NASDAQ:CFRX)

StockNews.com initiated coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Trading Down 28.0 % Shares of NASDAQ:CFRX opened at $0.05 on Thursday. ContraFect has a 12-month low of $0.04 and a 12-month high […] ....

United States , Vanguard Group Inc , Envestnet Asset Management Inc , Dimensional Fund Advisors , Goldman Sachs Group Inc , Contrafect Corporation , Free Report , Fect Trading Down , Get Free Report , Asset Management , Fund Advisors , Street Corp , Goldman Sachs Group , Sachs Group , Fect Corporation , Contrafect Daily , Nasdaq Cfrx , Initiated Coverage , Stocknews Com ,